TrademarkDir
ACCREDO ONE ADHERENCE
LIVE

Serial Number

97398433

Owner

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.

Attorney

Troy E. Larson

First Use Date

Oct 17, 2024

Filing Date

May 6, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ACCREDO ONE ADHERENCE Trademark

Serial Number: 97398433 • Registration: 7940524

ACCREDO ONE ADHERENCE is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on May 6, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

May 6, 2022

Registration Date

September 9, 2025

First Use Anywhere

October 17, 2024

First Use in Commerce

October 17, 2024

Published for Opposition

April 18, 2023

Goods & Services

Advisory services and consultancy regarding healthcare; healthcare services, complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing information regarding health and safety issues regarding chronic conditions; providing medical information and medical analysis services for diagnostic and treatment purposes in the fields of healthcare, pharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers; Prescription refill reminder services; remote monitoring of medical data indicative of the health and condition of an individual and groups of individuals for medical diagnosis and treatment purposes, namely, patient medication dosage, usage and adherence; providing healthcare and medication information to patients by telephone; medical services, namely, providing patient education in the nature of providing information to patients in the field of medication administration, storage, adherence, and side effects and medical consultations over the telephone; telemedicine services; providing information to patients in the field of administering medications

Providing a website featuring technology that enables users to monitor prescription medication adherence

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 9, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 18, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 18, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2025 CRFA
ASSIGNED TO LIE
Jul 18, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 29, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 29, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 10, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 10, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 1, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 31, 2025 AITU
USE AMENDMENT FILED
Nov 15, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 15, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 12, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 12, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 12, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 12, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 12, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 12, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 13, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 16, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 16, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 27, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2022 NWOS
NEW APPLICATION ENTERED
May 10, 2022 NWAP

Related Trademarks

More from this Owner

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE